AMAT vs IMMX · P/E 56, rev $24.04B vs $640.7M cap
Applied Materials Inc (AMAT) versus Immix Biopharma Inc (IMMX) — a side-by-side from cached financials, not a winner call.
Applied Materials Inc (AMAT) is a semiconductor equipment & materials company listed on NASDAQ.
Immix Biopharma Inc (IMMX) is a biotechnology company listed on US.
Latest reported AMAT revenue for 2026-07-26 was $24.04B. Net income was $7.37B. AMAT currently screens at market cap $470.75B and trailing P/E 55.8.
IMMX does not have a complete income-statement cache yet.
AMAT currently screens at market cap $470.75B and trailing P/E 55.8. IMMX currently screens at market cap $640.7M.
Not investment advice. Open the AMAT and IMMX stock pages for the full models.
Not investment advice.